Discovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitors.
Bode, C.M., Boezio, A.A., Albrecht, B.K., Bellon, S.F., Berry, L., Broome, M.A., Choquette, D., Dussault, I., Lewis, R.T., Lin, M.H., Rex, K., Whittington, D.A., Yang, Y., Harmange, J.C.(2012) Bioorg.Med.Chem.Lett. 22: 4089-4093
- PubMed: 22595176 
- DOI: 10.1016/j.bmcl.2012.04.072
- Primary Citation of Related Structures:  
- PubMed Abstract: 
Deregulation of the receptor tyrosine kinase c-Met has been implicated in several human cancers and is an attractive target for small molecule drug discovery. Herein, we report the discovery of a structurally diverse series of carbon-linked quinoline ...